A study to evaluate the first dose of gentamicin needed to achieve a peak plasma concentration of 30 mg/l in patients hospitalized for severe sepsis

Eur J Clin Microbiol Infect Dis. 2016 Jul;35(7):1187-93. doi: 10.1007/s10096-016-2652-6. Epub 2016 May 3.

Abstract

Previous studies have shown that the high dose of gentamicin (8 mg/kg) rarely achieves the desired peak plasma concentration (Cmax) of ≥30 mg/l in patients with severe sepsis or septic shock. The aim of this study was to determine the first dose of gentamicin needed to achieve a Cmax ≥ 30 mg/l. We conducted a prospective observational cohort study in one intensive care unit. All consecutive patients hospitalized for severe sepsis or septic shock and treated with a first dose of gentamicin >6 mg/kg were evaluated. During the study period, 15 of the 57 patients (26.3 %) treated with gentamicin had a Cmax ≥ 30 mg/l. The median dose of gentamicin administered was 8.9 [7.8-9.9] mg/kg. Independent factors in the multivariate analysis associated with a Cmax ≥ 30 mg/l were higher body mass index (per kg/m(2) increment) (OR: 1.173, 95%CI: 1.015-1.356, P = 0.03) and higher first dose of gentamicin (per mg/kg increment) (OR: 2.343, 95%CI: 1.346-4.08, P = 0.003). The optimal first dose to achieve a Cmax ≥ 30 mg/l was 11 mg/kg, with a specificity and a sensitivity of 100 % and 53.3 % respectively. These results suggest that a first dose of gentamicin >11 mg/kg is needed to achieve a Cmax ≥ 30 mg/l in most patients.

MeSH terms

  • Aged
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacokinetics*
  • Comorbidity
  • Drug Monitoring
  • Female
  • Gentamicins / administration & dosage*
  • Gentamicins / pharmacokinetics*
  • Hospitalization
  • Humans
  • Intensive Care Units
  • Male
  • Middle Aged
  • Prognosis
  • Risk Factors
  • Sepsis / diagnosis
  • Sepsis / drug therapy*
  • Sepsis / mortality
  • Severity of Illness Index
  • Shock, Septic / diagnosis
  • Shock, Septic / drug therapy
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Gentamicins